DELAWARE
|
811-21702
|
20-2433262
|
||
(State
or other jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
||
of
incorporation)
|
Identification
No.)
|
|||
40
East 52nd Street
|
10022
|
|||
New
York, New York
|
||||
(Address
of principal executive offices)
|
(Zip
Code)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
||
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d- 2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13-4(c))
|
Item
7.01
|
Regulation
FD Disclosure.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits
|
3.1
|
Amended
and Restated Bylaws of BlackRock Health Sciences
Trust
|
BlackRock
Health Sciences Trust
|
||||||
By:
|
/s/
Howard B. Surloff
|
|||||
Name:
|
Howard
B. Surloff
|
|||||
Title:
|
Secretary
|
|||||
DATE: October
7, 2008
|
Exhibit
No.
|
Description
|
3.1
|
Amended
and Restated Bylaws of BlackRock Health Sciences
Trust
|